id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02278315 | 1:14:treatment, | Major surgery within 6 weeks of enrollment | 3 | [
"Major",
"surgery",
"within",
"6",
"weeks",
"of",
"enrollment"
] | [
1,
1,
0,
0,
0,
0,
0
] |
NCT02589938 | 19:43:treatment, | Have received any investigational new drug within the past 30 days or planning to receive such during the study period | 3 | [
"Have",
"received",
"any",
"investigational",
"new",
"drug",
"within",
"the",
"past",
"30",
"days",
"or",
"planning",
"to",
"receive",
"such",
"during",
"the",
"study",
"period"
] | [
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02578732 | 27:38:allergy_name,42:52:allergy_name | Prior hypersensitivity to Oxaliplatin or Abraxane ® that in the investigators opinion would put the patient at risk if re-exposed | 3 | [
"Prior",
"hypersensitivity",
"to",
"Oxaliplatin",
"or",
"Abraxane",
"®",
"that",
"in",
"the",
"investigators",
"opinion",
"would",
"put",
"the",
"patient",
"at",
"risk",
"if",
"re-exposed"
] | [
0,
0,
0,
4,
0,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00412594 | ,,,53:66:chronic_disease | New York Heart Association Classification III or IV heart disease (See Appendix I) | 3 | [
"New",
"York",
"Heart",
"Association",
"Classification",
"III",
"or",
"IV",
"heart",
"disease",
"(",
"See",
"Appendix",
"I",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02308202 | 6:18:chronic_disease,22:43:chronic_disease,53:62:chronic_disease,66:81:chronic_disease | Have neurological or psychiatric disorders, such as psychosis or bipolar illness as assessed by Structural Clinical Interview for DSM disorders (SCID) | 3 | [
"Have",
"neurological",
"or",
"psychiatric",
"disorders",
",",
"such",
"as",
"psychosis",
"or",
"bipolar",
"illness",
"as",
"assessed",
"by",
"Structural",
"Clinical",
"Interview",
"for",
"DSM",
"disorders",
"(",
"SCID",
")"
] | [
0,
2,
0,
2,
2,
0,
0,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02556606 | 30:39:treatment,45:74:treatment,78:120:treatment | Patients currently receiving treatment with vagus nerve stimulation (VNS) or repetitive transcranial stimulation (rTMS) | 3 | [
"Patients",
"currently",
"receiving",
"treatment",
"with",
"vagus",
"nerve",
"stimulation",
"(",
"VNS",
")",
"or",
"repetitive",
"transcranial",
"stimulation",
"(",
"rTMS",
")"
] | [
0,
0,
0,
1,
0,
1,
1,
1,
1,
0,
0,
0,
1,
1,
1,
1,
0,
0
] |
NCT02107703 | ,86:112:treatment,200:295:treatment,300:318:cancer | relapsed with radiologic evidence of progression more than 1 year from completion of adjuvant endocrine therapy and then subsequently relapsed with radiologic evidence of progression after receiving treatment with either an antiestrogen or an aromatase inhibitor as first-line endocrine therapy for metastatic disease | 3 | [
"relapsed",
"with",
"radiologic",
"evidence",
"of",
"progression",
"more",
"than",
"1",
"year",
"from",
"completion",
"of",
"adjuvant",
"endocrine",
"therapy",
"and",
"then",
"subsequently",
"relapsed",
"with",
"radiologic",
"evidence",
"of",
"progression",
"after",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
3,
3
] |
NCT02357784 | 7:25:chronic_disease | has a neurologic disease | 3 | [
"has",
"a",
"neurologic",
"disease"
] | [
0,
0,
2,
2
] |
NCT03074240 | 32:40:allergy_name | True allergy, not sensitivity, Propofol | 3 | [
"True",
"allergy",
",",
"not",
"sensitivity",
",",
"Propofol"
] | [
0,
0,
0,
0,
0,
0,
4
] |
NCT01928589 | 79:93:cancer | Patient must have histologically confirmed (by routine H&E staining) invasive adenocarcinoma of the breast | 3 | [
"Patient",
"must",
"have",
"histologically",
"confirmed",
"(",
"by",
"routine",
"H",
"&",
"E",
"staining",
")",
"invasive",
"adenocarcinoma",
"of",
"the",
"breast"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0
] |
NCT02050113 | 13:30:chronic_disease,32:42:chronic_disease,47:60:chronic_disease | Significant occlusive disease, tortuosity, or calcification that would prevent endovascular access | 3 | [
"Significant",
"occlusive",
"disease",
",",
"tortuosity",
",",
"or",
"calcification",
"that",
"would",
"prevent",
"endovascular",
"access"
] | [
0,
2,
2,
0,
2,
0,
0,
2,
0,
0,
0,
0,
0
] |
NCT01631617 | 46:55:treatment,57:82:treatment,84:105:treatment,110:137:treatment,,,220:229:treatment | Subjects receiving or planning to receive an IND agent, ultraviolet light therapy, monoclonal antibodies, or systemic immunosuppressants within 7 days or 5 half-lives (whichever is the longer time period) of initiating treatment on this protocol | 3 | [
"Subjects",
"receiving",
"or",
"planning",
"to",
"receive",
"an",
"IND",
"agent",
",",
"ultraviolet",
"light",
"therapy",
",",
"monoclonal",
"antibodies",
",",
"or",
"systemic",
"immunosuppressants",
"within",
"7",
"days",
"or",
"5",
"half-lives",
"(",
"whicheve... | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
1,
1,
0,
1,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT00432094 | ,,34:45:treatment,, | Platelets > 100 x 10^9/L without transfusion and/or a bone marrow cellularity of ≥ 20% | 3 | [
"Platelets",
">",
"100",
"x",
"10^9/L",
"without",
"transfusion",
"and/or",
"a",
"bone",
"marrow",
"cellularity",
"of",
"≥",
"20",
"%"
] | [
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01905046 | 14:26:treatment,41:61:chronic_disease,63:95:cancer,100:131:cancer | Having had a prior biopsy demonstrating atypical hyperplasia, lobular carcinoma in situ (LCIS), or ductal carcinoma in situ (DCIS) | 3 | [
"Having",
"had",
"a",
"prior",
"biopsy",
"demonstrating",
"atypical",
"hyperplasia",
",",
"lobular",
"carcinoma",
"in",
"situ",
"(",
"LCIS",
")",
",",
"or",
"ductal",
"carcinoma",
"in",
"situ",
"(",
"DCIS",
")"
] | [
0,
0,
0,
1,
1,
0,
2,
2,
0,
3,
3,
3,
3,
3,
0,
0,
0,
0,
3,
3,
3,
3,
3,
0,
0
] |
NCT02758847 | 1:17:chronic_disease | Immunosuppressed patients | 3 | [
"Immunosuppressed",
"patients"
] | [
2,
0
] |
NCT03033498 | 43:64:treatment | Use of any medication from the prohibited concomitant therapies | 3 | [
"Use",
"of",
"any",
"medication",
"from",
"the",
"prohibited",
"concomitant",
"therapies"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03069469 | 1:14:treatment, | Major surgery within 2 weeks of the first dose of study drug | 3 | [
"Major",
"surgery",
"within",
"2",
"weeks",
"of",
"the",
"first",
"dose",
"of",
"study",
"drug"
] | [
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02687906 | 8:17:treatment,, | Use of meropenem within 48 hours of administration of study drug or 12 hours after study drug administration | 3 | [
"Use",
"of",
"meropenem",
"within",
"48",
"hours",
"of",
"administration",
"of",
"study",
"drug",
"or",
"12",
"hours",
"after",
"study",
"drug",
"administration"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03154580 | 93:108:treatment | Past-month exposure to medications that increase study risk (e.g. toxicity to major organs, asthma inhalers) | 3 | [
"Past-month",
"exposure",
"to",
"medications",
"that",
"increase",
"study",
"risk",
"(",
"e.g",
".",
"toxicity",
"to",
"major",
"organs",
",",
"asthma",
"inhalers",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0
] |
NCT01967823 | 1:11:chronic_disease | HLA-A*0201 positive | 3 | [
"HLA-A",
"*",
"0201",
"positive"
] | [
2,
2,
2,
2
] |
NCT02456857 | 1:25:cancer,31:62:cancer,64:70:cancer,75:81:cancer, | non-melanoma skin cancer, and carcinoma in situ of the cervix, uterus, or breast from which the patient has been disease free for =< 3 years | 3 | [
"non-melanoma",
"skin",
"cancer",
",",
"and",
"carcinoma",
"in",
"situ",
"of",
"the",
"cervix",
",",
"uterus",
",",
"or",
"breast",
"from",
"which",
"the",
"patient",
"has",
"been",
"disease",
"free",
"for",
"=",
"<",
"3",
"years"
] | [
3,
3,
3,
0,
0,
3,
3,
3,
3,
3,
3,
0,
3,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02519283 | 40:59:chronic_disease | Unable to comply with protocol- due to psychiatric disease or distance from the hospital | 3 | [
"Unable",
"to",
"comply",
"with",
"protocol-",
"due",
"to",
"psychiatric",
"disease",
"or",
"distance",
"from",
"the",
"hospital"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02519140 | 16:34:treatment | Pts undergoing sleeve gastrectomy | 3 | [
"Pts",
"undergoing",
"sleeve",
"gastrectomy"
] | [
0,
0,
1,
1
] |
NCT02565901 | 1:37:cancer,, | Castration resistant prostate cancer as defined by serum testosterone < 50 ng/ml | 3 | [
"Castration",
"resistant",
"prostate",
"cancer",
"as",
"defined",
"by",
"serum",
"testosterone",
"<",
"50",
"ng/ml"
] | [
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03072381 | 17:61:treatment | currently using anticoagulation or immunosuppressive therapy | 3 | [
"currently",
"using",
"anticoagulation",
"or",
"immunosuppressive",
"therapy"
] | [
0,
0,
1,
1,
1,
1
] |
NCT02276443 | ,,,68:81:chronic_disease,97:118:chronic_disease,120:135:chronic_disease,139:169:chronic_disease, | Patients with a history of New York Heart Association class 3 or 4 heart failure, or history of myocardial infarction, unstable angina or cerebrovascular accident (CVA) within 6 months of protocol registration | 3 | [
"Patients",
"with",
"a",
"history",
"of",
"New",
"York",
"Heart",
"Association",
"class",
"3",
"or",
"4",
"heart",
"failure",
",",
"or",
"history",
"of",
"myocardial",
"infarction",
",",
"unstable",
"angina",
"or",
"cerebrovascular",
"accident",
"(",
"CVA",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03112902 | 1:12:chronic_disease | sleep apnea | 3 | [
"sleep",
"apnea"
] | [
2,
2
] |
NCT02694029 | 1:25:chronic_disease | unstable angina pectoris | 3 | [
"unstable",
"angina",
"pectoris"
] | [
2,
2,
2
] |
NCT02359097 | 63:78:allergy_name,80:98:allergy_name,100:123:allergy_name,128:171:allergy_name | Subjects with known allergic or hypersensitivity reactions to parenteral iron, parenteral dextran, parenteral iron-dextran, or parenteral iron-polysaccharide preparations | 3 | [
"Subjects",
"with",
"known",
"allergic",
"or",
"hypersensitivity",
"reactions",
"to",
"parenteral",
"iron",
",",
"parenteral",
"dextran",
",",
"parenteral",
"iron-dextran",
",",
"or",
"parenteral",
"iron-polysaccharide",
"preparations"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
4,
4,
4,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02576912 | 12:20:treatment | Exposed to cannabis at least once in lifetime | 3 | [
"Exposed",
"to",
"cannabis",
"at",
"least",
"once",
"in",
"lifetime"
] | [
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02389465 | 4:23:chronic_disease | No renal insufficiency | 3 | [
"No",
"renal",
"insufficiency"
] | [
0,
2,
2
] |
NCT03187379 | 27:47:treatment | patients undergoing other bariatric procedures | 3 | [
"patients",
"undergoing",
"other",
"bariatric",
"procedures"
] | [
0,
0,
0,
1,
1
] |
NCT02836574 | 14:30:chronic_disease,36:59:chronic_disease,64:87:chronic_disease,96:130:chronic_disease | positive for active infection with Hepatitis B Virus (HBV), or Hepatitis C Virus (HCV), and/or Human Immunodeficiency Virus (HIV) as assessed at the Screening Visit | 3 | [
"positive",
"for",
"active",
"infection",
"with",
"Hepatitis",
"B",
"Virus",
"(",
"HBV",
")",
",",
"or",
"Hepatitis",
"C",
"Virus",
"(",
"HCV",
")",
",",
"and/or",
"Human",
"Immunodeficiency",
"Virus",
"(",
"HIV",
")",
"as",
"assessed",
"at",
"the",
"Scr... | [
0,
0,
2,
2,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02338999 | 28:39:chronic_disease,41:52:chronic_disease,54:57:chronic_disease,61:73:chronic_disease | Chronic infections such as hepatitis B, hepatitis C, HIV or Tuberculosis | 3 | [
"Chronic",
"infections",
"such",
"as",
"hepatitis",
"B",
",",
"hepatitis",
"C",
",",
"HIV",
"or",
"Tuberculosis"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
2,
0,
2
] |
NCT03059004 | 1:24:treatment | Intra-articular therapy in last 4 weeks | 3 | [
"Intra-articular",
"therapy",
"in",
"last",
"4",
"weeks"
] | [
1,
1,
0,
0,
0,
0
] |
NCT02729350 | 5:8:chronic_disease | Has SCD diagnosis | 3 | [
"Has",
"SCD",
"diagnosis"
] | [
0,
2,
0
] |
NCT02235857 | 30:44:treatment,,105:124:treatment,318:331:treatment | Currently being administered ACE inhibitors that cannot be withheld for at least 24 hours prior to each apheresis treatment (Note: The time period to withhold ACE inhibitors should be prolonged, if determined by the treating physician, considering each individual's renal function and the biological half-life of the ACE... | 3 | [
"Currently",
"being",
"administered",
"ACE",
"inhibitors",
"that",
"can",
"not",
"be",
"withheld",
"for",
"at",
"least",
"24",
"hours",
"prior",
"to",
"each",
"apheresis",
"treatment",
"(",
"Note",
":",
"The",
"time",
"period",
"to",
"withhold",
"ACE",
"inhi... | [
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0
] |
NCT02543983 | 64:78:treatment,80:98:treatment,100:128:treatment,133:151:treatment,153:169:treatment,174:193:treatment | Participants with metal objects implanted in the body, such as aneurysm clips, neural stimulators, implanted cardiac pacemakers, or auto-defibrillator, cochlear implant, or ocular foreign body which would make having an MRI scan unsafe | 3 | [
"Participants",
"with",
"metal",
"objects",
"implanted",
"in",
"the",
"body",
",",
"such",
"as",
"aneurysm",
"clips",
",",
"neural",
"stimulators",
",",
"implanted",
"cardiac",
"pacemakers",
",",
"or",
"auto-defibrillator",
",",
"cochlear",
"implant",
",",
"or",... | [
0,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02990455 | 27:35:chronic_disease,37:45:chronic_disease,50:64:chronic_disease | Self-report of history of seizures, delirium, or hallucinations during alcohol withdrawal | 3 | [
"Self-report",
"of",
"history",
"of",
"seizures",
",",
"delirium",
",",
"or",
"hallucinations",
"during",
"alcohol",
"withdrawal"
] | [
0,
0,
0,
0,
2,
0,
2,
0,
0,
2,
0,
0,
0
] |
NCT03179449 | 26:40:treatment | Contraindication to MRI (metal implants) | 3 | [
"Contraindication",
"to",
"MRI",
"(",
"metal",
"implants",
")"
] | [
0,
0,
0,
0,
1,
1,
0
] |
NCT02975869 | 1:23:cancer | Primary refractory AML | 3 | [
"Primary",
"refractory",
"AML"
] | [
3,
3,
3
] |
NCT02338999 | 16:40:treatment,, | Receipt of any investigational new drug or device within 30 days prior to screening or 5 half-lives of the agent <TAB>(whichever is longer), or any investigational new drug with known long-term effects | 3 | [
"Receipt",
"of",
"any",
"investigational",
"new",
"drug",
"or",
"device",
"within",
"30",
"days",
"prior",
"to",
"screening",
"or",
"5",
"half-lives",
"of",
"the",
"agent",
"<",
"TAB",
">",
"(",
"whichever",
"is",
"longer",
")",
",",
"or",
"any",
"invest... | [
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02724540 | 1:29:treatment | transpapillary biliary stent | 3 | [
"transpapillary",
"biliary",
"stent"
] | [
1,
1,
1
] |
NCT02931110 | 1:13:treatment | fondaparinux | 3 | [
"fondaparinux"
] | [
1
] |
NCT02493257 | 12:29:treatment | History of sinonasal surgery | 3 | [
"History",
"of",
"sinonasal",
"surgery"
] | [
0,
0,
1,
1
] |
NCT02414269 | ,,218:228:treatment,,,, | Subjects and their partners with reproductive potential must agree to use an effective form of contraception during the period of drug administration and for 4 weeks after completion of the last administration of the study drug. An effective form of contraception is defined as oral contraceptives plus 1 form of barrier... | 3 | [
"Subjects",
"and",
"their",
"partners",
"with",
"reproductive",
"potential",
"must",
"agree",
"to",
"use",
"an",
"effective",
"form",
"of",
"contraception",
"during",
"the",
"period",
"of",
"drug",
"administration",
"and",
"for",
"4",
"weeks",
"after",
"completi... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT01625923 | 12:30:chronic_disease | History of hepatic impairment | 3 | [
"History",
"of",
"hepatic",
"impairment"
] | [
0,
0,
2,
2
] |
NCT02428205 | 66:83:treatment | Any of the following exclusionary criteria related to the use of electrocardiogram (history of rash from adhesives) | 3 | [
"Any",
"of",
"the",
"following",
"exclusionary",
"criteria",
"related",
"to",
"the",
"use",
"of",
"electrocardiogram",
"(",
"history",
"of",
"rash",
"from",
"adhesives",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0
] |
NCT02522468 | 1:35:chronic_disease | Multifocal or multicentric disease | 3 | [
"Multifocal",
"or",
"multicentric",
"disease"
] | [
2,
2,
2,
2
] |
NCT02459119 | ,,,121:131:treatment | Women of childbearing potential must have a negative serum pregnancy test performed within 7 days prior to the start of study drug | 3 | [
"Women",
"of",
"childbearing",
"potential",
"must",
"have",
"a",
"negative",
"serum",
"pregnancy",
"test",
"performed",
"within",
"7",
"days",
"prior",
"to",
"the",
"start",
"of",
"study",
"drug"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02519322 | ,,,68:89:treatment | Absolute neutrophil count (ANC) >= 1.5 X 10^9/L (within 28 days of first study treatment) | 3 | [
"Absolute",
"neutrophil",
"count",
"(",
"ANC",
")",
">",
"=",
"1.5",
"X",
"10^9/L",
"(",
"within",
"28",
"days",
"of",
"first",
"study",
"treatment",
")"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
0
] |
NCT00670358 | 4:28:chronic_disease,59:66:treatment,88:111:chronic_disease | No congestive heart failure requiring ongoing maintenance therapy for life-threatening ventricular arrhythmias | 3 | [
"No",
"congestive",
"heart",
"failure",
"requiring",
"ongoing",
"maintenance",
"therapy",
"for",
"life-threatening",
"ventricular",
"arrhythmias"
] | [
0,
2,
2,
2,
0,
0,
0,
1,
0,
0,
2,
2
] |
NCT02078102 | 1:20:cancer | Follicular lymphoma (any grade) | 3 | [
"Follicular",
"lymphoma",
"(",
"any",
"grade",
")"
] | [
3,
3,
0,
0,
0,
0
] |
NCT03019367 | 1:8:chronic_disease | Hydrops | 3 | [
"Hydrops"
] | [
2
] |
NCT02446457 | 14:274:treatment,266:274:treatment,286:296:treatment,322:326:treatment | Has received prior therapy with an anti-programmed cell death 1 (PD-1), anti-programmed cell death ligand 1 (PD-L1), anti-programmed cell death ligand 2 (PD-L2), anti- cluster of differentiation (CD)137, or anti-cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) antibody (including ipilimumab or any other antibody or... | 3 | [
"Has",
"received",
"prior",
"therapy",
"with",
"an",
"anti-programmed",
"cell",
"death",
"1",
"(",
"PD-1",
")",
",",
"anti-programmed",
"cell",
"death",
"ligand",
"1",
"(",
"PD-L1",
")",
",",
"anti-programmed",
"cell",
"death",
"ligand",
"2",
"(",
"PD-L2",
... | [
0,
0,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0... |
NCT01697371 | 8:19:treatment,, | use of transfusion or other intervention to achieve Hgb ≥ 8.0 is acceptable | 3 | [
"use",
"of",
"transfusion",
"or",
"other",
"intervention",
"to",
"achieve",
"Hgb",
"≥",
"8.0",
"is",
"acceptable"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01697371 | 7:26:cancer,38:47:cancer,64:92:cancer, | Prior invasive malignancy other than liver met primary (except non-melanomatous skin cancer) unless disease free for > 3years | 3 | [
"Prior",
"invasive",
"malignancy",
"other",
"than",
"liver",
"met",
"primary",
"(",
"except",
"non-melanomatous",
"skin",
"cancer",
")",
"unless",
"disease",
"free",
"for",
">",
"3years"
] | [
0,
3,
3,
0,
0,
3,
3,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0
] |
NCT02464878 | 38:58:treatment | other technical reasons that require graft pancreatectomy | 3 | [
"other",
"technical",
"reasons",
"that",
"require",
"graft",
"pancreatectomy"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT02252588 | 8:19:cancer,,85:99:treatment,103:118:treatment | Active lung cancer or history of lung cancer if it has been less than 2 years since lung resection or other treatment | 3 | [
"Active",
"lung",
"cancer",
"or",
"history",
"of",
"lung",
"cancer",
"if",
"it",
"has",
"been",
"less",
"than",
"2",
"years",
"since",
"lung",
"resection",
"or",
"other",
"treatment"
] | [
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02053246 | 1:28:chronic_disease | Decompensated heart failure | 3 | [
"Decompensated",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT02131467 | 1:17:chronic_disease | Active infection | 3 | [
"Active",
"infection"
] | [
2,
2
] |
NCT02823665 | 8:13:chronic_disease,15:19:chronic_disease,21:26:chronic_disease,28:44:chronic_disease,48:62:chronic_disease | Active heart, lung, liver, gastrointestinal or kidney disease | 3 | [
"Active",
"heart",
",",
"lung",
",",
"liver",
",",
"gastrointestinal",
"or",
"kidney",
"disease"
] | [
0,
2,
0,
2,
0,
2,
0,
2,
0,
2,
2
] |
NCT02847988 | 1:16:chronic_disease | Cardiopulmonary Instability | 3 | [
"Cardiopulmonary",
"Instability"
] | [
2,
0
] |
NCT01620216 | 39:62:chronic_disease,72:95:chronic_disease,97:121:chronic_disease,126:145:chronic_disease | Any history of clinically significant ventricular arrhythmias (such as ventricular tachycardia, ventricular fibrillation, or torsades de pointes) | 3 | [
"Any",
"history",
"of",
"clinically",
"significant",
"ventricular",
"arrhythmias",
"(",
"such",
"as",
"ventricular",
"tachycardia",
",",
"ventricular",
"fibrillation",
",",
"or",
"torsades",
"de",
"pointes",
")"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0
] |
NCT02347891 | 1:15:treatment, | Pulse steroids 2 months prior to Screening | 3 | [
"Pulse",
"steroids",
"2",
"months",
"prior",
"to",
"Screening"
] | [
1,
1,
0,
0,
0,
0,
0
] |
NCT01494662 | 58:76:cancer,113:123:cancer,144:160:treatment | Patients without pathologic or cytologic confirmation of metastatic disease should have unequivocal evidence of metastasis by physical exam or radiologic study | 3 | [
"Patients",
"without",
"pathologic",
"or",
"cytologic",
"confirmation",
"of",
"metastatic",
"disease",
"should",
"have",
"unequivocal",
"evidence",
"of",
"metastasis",
"by",
"physical",
"exam",
"or",
"radiologic",
"study"
] | [
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
1,
1
] |
NCT02516670 | 5:56:chronic_disease | Has glucose-6-phosphate dehydrogenase (G6PD) deficiency | 3 | [
"Has",
"glucose-6-phosphate",
"dehydrogenase",
"(",
"G6PD",
")",
"deficiency"
] | [
0,
2,
2,
2,
2,
0,
0
] |
NCT02863809 | 29:55:treatment | including fever and current treatment with antibiotics | 3 | [
"including",
"fever",
"and",
"current",
"treatment",
"with",
"antibiotics"
] | [
0,
0,
0,
0,
1,
1,
1
] |
NCT01648023 | 21:31:cancer,54:80:cancer,85:137:cancer | Presence of another malignancy with the exception of cervical carcinoma in situ and stage I basal or squamous cell carcinoma of the skin | 3 | [
"Presence",
"of",
"another",
"malignancy",
"with",
"the",
"exception",
"of",
"cervical",
"carcinoma",
"in",
"situ",
"and",
"stage",
"I",
"basal",
"or",
"squamous",
"cell",
"carcinoma",
"of",
"the",
"skin"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
3,
3,
0,
3,
3,
3,
3,
3,
3,
3,
3,
3,
3
] |
NCT01648023 | 6:27:chronic_disease,34:42:chronic_disease,46:51:cancer | Main portal vein occlusion (e.g. thrombus or tumor) | 3 | [
"Main",
"portal",
"vein",
"occlusion",
"(",
"e.g",
".",
"thrombus",
"or",
"tumor",
")"
] | [
0,
2,
2,
2,
0,
0,
0,
2,
0,
3,
0
] |
NCT02019940 | 32:46:chronic_disease | Clinical evidence of untreated hypothyroidism | 3 | [
"Clinical",
"evidence",
"of",
"untreated",
"hypothyroidism"
] | [
0,
0,
0,
0,
2
] |
NCT02343042 | 1:33:chronic_disease | Uncontrolled active hypertension | 3 | [
"Uncontrolled",
"active",
"hypertension"
] | [
2,
2,
2
] |
NCT02271919 | 42:75:treatment, | Current enrollment or plans to enroll in another smoking cessation program in the next 12 months | 3 | [
"Current",
"enrollment",
"or",
"plans",
"to",
"enroll",
"in",
"another",
"smoking",
"cessation",
"program",
"in",
"the",
"next",
"12",
"months"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
0,
0,
0,
0,
0
] |
NCT02600156 | 1:26:cancer | Clinical stage T1c or T2a | 3 | [
"Clinical",
"stage",
"T1c",
"or",
"T2a"
] | [
3,
3,
3,
3,
3
] |
NCT02826343 | 12:33:chronic_disease, | History of respiratory infection within 2 weeks prior to the MR scan | 3 | [
"History",
"of",
"respiratory",
"infection",
"within",
"2",
"weeks",
"prior",
"to",
"the",
"MR",
"scan"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03072381 | 12:18:treatment | concurrent opioid use for pain | 3 | [
"concurrent",
"opioid",
"use",
"for",
"pain"
] | [
0,
1,
0,
0,
0
] |
NCT03145298 | 15:22:chronic_disease | Patients with PAH-HIV | 3 | [
"Patients",
"with",
"PAH-HIV"
] | [
0,
0,
2
] |
NCT03028831 | 1:8:chronic_disease | hepatic | 3 | [
"hepatic"
] | [
2
] |
NCT02313753 | 1:21:chronic_disease,, | Cognitive impairment which would interfere with adequate participation in the project (MMSE< 20) | 3 | [
"Cognitive",
"impairment",
"which",
"would",
"interfere",
"with",
"adequate",
"participation",
"in",
"the",
"project",
"(",
"MMSE",
"<",
"20",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02555280 | ,21:30:chronic_disease,, | Visual Analog Scale back pain score of at least 50 mm on a 100 mm scale | 3 | [
"Visual",
"Analog",
"Scale",
"back",
"pain",
"score",
"of",
"at",
"least",
"50",
"mm",
"on",
"a",
"100",
"mm",
"scale"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02299414 | 26:46:chronic_disease | Known secondary cause of chronic hypertension | 3 | [
"Known",
"secondary",
"cause",
"of",
"chronic",
"hypertension"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02200445 | 29:46:chronic_disease | Positive screening test for tuberculosis (TB) | 3 | [
"Positive",
"screening",
"test",
"for",
"tuberculosis",
"(",
"TB",
")"
] | [
0,
0,
0,
0,
2,
2,
0,
0
] |
NCT02056288 | 1:12:chronic_disease | Sleep apnea by polysomnography | 3 | [
"Sleep",
"apnea",
"by",
"polysomnography"
] | [
2,
2,
0,
0
] |
NCT02431806 | 1:16:chronic_disease | Suicide attempt within the past year | 3 | [
"Suicide",
"attempt",
"within",
"the",
"past",
"year"
] | [
2,
2,
0,
0,
0,
0
] |
NCT02108860 | 1:10:chronic_disease,,,,,,,, | Cytopenia: platelet count < 100,000/mm3, white blood cell count (WBC) < 3,000/mm3 (3 x 109/L), absolute neutrophil count < 1500/mm3, hemoglobin (Hgb) < 8.5 g/dL | 3 | [
"Cytopenia",
":",
"platelet",
"count",
"<",
"100,000/mm3",
",",
"white",
"blood",
"cell",
"count",
"(",
"WBC",
")",
"<",
"3,000/mm3",
"(",
"3",
"x",
"109/L",
")",
",",
"absolute",
"neutrophil",
"count",
"<",
"1500/mm3",
",",
"hemoglobin",
"(",
"Hgb",
")"... | [
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02947347 | 1:32:cancer | Central nervous system lymphoma | 3 | [
"Central",
"nervous",
"system",
"lymphoma"
] | [
3,
3,
3,
3
] |
NCT02594111 | 1:15:treatment | clarithromycin | 3 | [
"clarithromycin"
] | [
1
] |
NCT01880567 | 17:20:cancer | Newly diagnosed MCL: Understand and voluntarily sign an IRB-approved informed consent form | 3 | [
"Newly",
"diagnosed",
"MCL",
":",
"Understand",
"and",
"voluntarily",
"sign",
"an",
"IRB-approved",
"informed",
"consent",
"form"
] | [
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01861106 | 1:11:treatment | Filgrastim may be secreted in human milk, although its bioavailability from this source is not known | 3 | [
"Filgrastim",
"may",
"be",
"secreted",
"in",
"human",
"milk",
",",
"although",
"its",
"bioavailability",
"from",
"this",
"source",
"is",
"not",
"known"
] | [
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00928356 | 39:51:treatment | Anatomy and body habitus suitable for Robotic CABG | 3 | [
"Anatomy",
"and",
"body",
"habitus",
"suitable",
"for",
"Robotic",
"CABG"
] | [
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT03144245 | 1:28:treatment, | Prior allogeneic transplant < 3 months prior to start date of AMV564 | 3 | [
"Prior",
"allogeneic",
"transplant",
"<",
"3",
"months",
"prior",
"to",
"start",
"date",
"of",
"AMV564"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02563678 | 1:15:chronic_disease,, | Morbidly obese (body mass index > 40 kg/m2) | 3 | [
"Morbidly",
"obese",
"(",
"body",
"mass",
"index",
">",
"40",
"kg/m2",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01962415 | 1:14:chronic_disease | IPEX syndrome | 3 | [
"IPEX",
"syndrome"
] | [
2,
2
] |
NCT03009981 | 1:37:treatment,44:56:treatment,58:77:treatment,79:89:treatment,94:140:treatment,151:162:treatment,166:178:treatment | Prior treatment with CYP17 inhibitor (e.g. ketoconazole, abiraterone acetate, galeterone) or second generation androgen receptor antagonist including apalutamide or enzalutamide | 3 | [
"Prior",
"treatment",
"with",
"CYP17",
"inhibitor",
"(",
"e.g",
".",
"ketoconazole",
",",
"abiraterone",
"acetate",
",",
"galeterone",
")",
"or",
"second",
"generation",
"androgen",
"receptor",
"antagonist",
"including",
"apalutamide",
"or",
"enzalutamide"
] | [
1,
1,
1,
1,
1,
0,
0,
0,
1,
0,
1,
1,
0,
1,
0,
0,
1,
1,
1,
1,
1,
0,
1,
0,
1
] |
NCT02349958 | 39:49:cancer,,85:109:cancer,148:157:allergy_name,159:170:allergy_name,175:185:allergy_name | Patients with any evidence of another malignancy within the last five years (except non-melanoma skin cancer) Patients with a known sensitivity to cisplatin, Mitomycin C, or Adriamycin | 3 | [
"Patients",
"with",
"any",
"evidence",
"of",
"another",
"malignancy",
"within",
"the",
"last",
"five",
"years",
"(",
"except",
"non-melanoma",
"skin",
"cancer",
")",
"Patients",
"with",
"a",
"known",
"sensitivity",
"to",
"cisplatin",
",",
"Mitomycin",
"C",
","... | [
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
4,
0,
4,
4,
0,
0,
4
] |
NCT00338377 | 5:31:chronic_disease,42:65:treatment,67:88:chronic_disease,104:121:chronic_disease,129:143:chronic_disease,145:156:chronic_disease,160:173:chronic_disease,,,335:347:treatment,348:361:treatment | Any active systemic infections requiring intravenous antibiotics, coagulation disorders or other major medical illnesses of the cardiovascular, respiratory or immune system, such as abnormal stress test and/or abnormal PFT. PI or his designee shall make the final determination regarding appropriateness of enrollment.(T... | 3 | [
"Any",
"active",
"systemic",
"infections",
"requiring",
"intravenous",
"antibiotics",
",",
"coagulation",
"disorders",
"or",
"other",
"major",
"medical",
"illnesses",
"of",
"the",
"cardiovascular",
",",
"respiratory",
"or",
"immune",
"system",
",",
"such",
"as",
"... | [
0,
2,
2,
2,
0,
1,
1,
0,
2,
2,
0,
0,
0,
2,
2,
0,
0,
2,
0,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02251431 | 83:103:treatment,107:113:treatment,121:133:treatment | Patient is enrolled in another experimental protocol which involves the use of an investigational drug or device, or an intervention that would interfere with the conduct of the trial | 3 | [
"Patient",
"is",
"enrolled",
"in",
"another",
"experimental",
"protocol",
"which",
"involves",
"the",
"use",
"of",
"an",
"investigational",
"drug",
"or",
"device",
",",
"or",
"an",
"intervention",
"that",
"would",
"interfere",
"with",
"the",
"conduct",
"of",
"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
1,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02140554 | 27:40:chronic_disease | suspected of arising from liver disease | 3 | [
"suspected",
"of",
"arising",
"from",
"liver",
"disease"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02469857 | ,61:75:chronic_disease | Patient who has been operated at least once for the current NSTI infection and had a curative deep tissue debridement | 3 | [
"Patient",
"who",
"has",
"been",
"operated",
"at",
"least",
"once",
"for",
"the",
"current",
"NSTI",
"infection",
"and",
"had",
"a",
"curative",
"deep",
"tissue",
"debridement"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02152956 | ,53:74:treatment | prior treatment failure with at least two cycles of hypomethylating agent | 3 | [
"prior",
"treatment",
"failure",
"with",
"at",
"least",
"two",
"cycles",
"of",
"hypomethylating",
"agent"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.